Docetaxel Labeled with Iodine 131 Radionuclide – A Possible New Anticancer Drug? (The Pilot Study)
The cytotoxic potentials of the lipiodol emulsion with dissolved 131I-docetaxel, the 131I-lipiodol emulsion and non-labeled docetaxel were tested on the HeLa Hep2 cell line during 24 hours. The pilot study confirmed that the radiolabeled docetaxel was significantly more toxic than the radionuclide o...
Main Authors: | Jiří Pastera, Emil Rudolf, Milan Dittrich |
---|---|
Format: | Article |
Language: | English |
Published: |
Karolinum Press
2006-01-01
|
Series: | Acta Medica |
Subjects: | |
Online Access: | https://actamedica.lfhk.cuni.cz/49/3/0189/ |
Similar Items
-
Transarterial radioembolization with Iodine-131-Lipiodol for hepatic metastases from gastrointestinal malignancies – Experience in tertiary care oncology center in India
by: Vidya Bhargavi, et al.
Published: (2019-01-01) -
Transarterial Radioembolization (TARE) with 131Iodine-Lipiodol for Unresectable Primary Hepatocellular Carcinoma: Experience from a Tertiary Care Center in India
by: Aakash Patel, et al.
Published: (2021-04-01) -
Labeling of Salmonella Typhymurium with iodine-131 to study phagocytic function in rats
by: Maria K. Sato, et al.
Published: (1989-06-01) -
The Effect of Radioactive Iodine (Iodine 131) on the Parameters of Sperm in Adult Male Rats
by: Fereshteh Dadfar, et al.
Published: (2018-10-01) -
Severe Hypertriglyceridemia Induced by Docetaxel: A Novel Case Report
by: Yoshitaka Saito, et al.
Published: (2021-09-01)